Muraglitazar is a PPAR alpha/gamma dual agonist for the research of type 2 diabetes and associated dyslipidemia. Muraglitazar shows potent activity in vitro at human PPARalpha (EC50 = 320 nM) and PPARgamma(EC50 = 110 nM)[1].
Molecular Weight:
516.54
Purity:
98.38
CAS Number:
[331741-94-7]
Formula:
C29H28N2O7
Target:
PPAR
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted